contact us krjpencn

뉴스현황

Market Activity

현재 위치: > 뉴스현황 > Market Activity > (DRUG DISCOVERY 2021...

(DRUG DISCOVERY 2021 ) RECONNECT WITH MEDICILON

저자:medicilon   업로드:2021-10-18  조회수:

DRUG DISCOVERY 2021: RECONNECT WITH MEDICILON

19-20 Oct. 2021, Medicilon welcomes you to join us at Europe’s largest meeting for life sciences industry professionals, ELRIG’s annual Drug Discovery meeting .

This year, Drug Discovery 2021 promises to be particularly special event, providing a platform for the whole drug discovery community to meet at a free to attend, in-person event, where members of ELRIG’s community may:

Re-connect with colleagues, as well as hear stories from scientists who have been responsible for combatting COVID-19 in the session tracks on infection and diagnostics.

Re-invent the process of drug discovery, by building diverse partnerships with even greater emphasis on efficiency, automation, and remote operation in our two session tracks of screening and chemistry.

Re-imagine and create a new vision for drug discovery, with insights from our innovation and disruptive strategies tracks.

Medicilon looks forward to meeting you at Booth #F15. With more than 17 years of experience in preclinical R&D, we’d like to build partnership with you and assist your drug R&D projects in:

Drug Discovery

Chemistry

Biology

Drug Development &CMC

Drug Substance

Drug Product

Preclinical Research

Pharmacology

Pharmacokinetics

Safety Assessment

Bioanalysis

IND Filing

FDA

NMPA

TGA

EMA

From its inception in 2004, Shanghai Medicilon Inc. (STAR Market stock code: 688202.SH) has been committed to providing comprehensive research and development (R&D) services to pharmaceutical companies, research institutions, and any organizations working in the preclinical space, with the primary objective of supporting and accelerating pharmaceutical, biopharmaceutical R&D worldwide.

이전:최고 임시

다음에:Join Medicilon at the AAPS 2021 PharmSci 360